Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.
COVID-19
SARS-CoV-2
detection
nanotechnology
treatment
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
24 06 2021
24 06 2021
Historique:
received:
01
06
2021
revised:
21
06
2021
accepted:
21
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
16
7
2021
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health problem that the WHO declared a pandemic. COVID-19 has resulted in a worldwide lockdown and threatened to topple the global economy. The mortality of COVID-19 is comparatively low compared with previous SARS outbreaks, but the rate of spread of the disease and its morbidity is alarming. This virus can be transmitted human-to-human through droplets and close contact, and people of all ages are susceptible to this virus. With the advancements in nanotechnology, their remarkable properties, including their ability to amplify signal, can be used for the development of nanobiosensors and nanoimaging techniques that can be used for early-stage detection along with other diagnostic tools. Nano-based protection equipment and disinfecting agents can provide much-needed protection against SARS-CoV-2. Moreover, nanoparticles can serve as a carrier for antigens or as an adjuvant, thereby making way for the development of a new generation of vaccines. The present review elaborates the role of nanotechnology-based tactics used for the detection, diagnosis, protection, and treatment of COVID-19 caused by the SARS-CoV-2 virus.
Identifiants
pubmed: 34202815
pii: v13071224
doi: 10.3390/v13071224
pmc: PMC8310263
pii:
doi:
Substances chimiques
Antiviral Agents
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Nanomedicine. 2014 Feb 20;9:1025-37
pubmed: 24591825
Mater Chem Phys. 2021 Jan 15;258:123943
pubmed: 33106717
J Clin Virol. 2019 Oct;119:44-52
pubmed: 31491709
ACS Appl Mater Interfaces. 2014 Sep 10;6(17):14745-66
pubmed: 24968359
Drug Deliv Transl Res. 2021 Aug;11(4):1309-1315
pubmed: 33512669
Front Immunol. 2020 Aug 07;11:1949
pubmed: 32849654
ACS Nano. 2023 Jan 10;17(1):697-710
pubmed: 36541630
Int J Nanomedicine. 2008;3(2):133-49
pubmed: 18686775
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Rheumatology (Oxford). 2020 Feb 1;59(2):292-302
pubmed: 31312844
Alzheimers Dement. 2021 Aug;17(8):1297-1306
pubmed: 33559975
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2003 May 15;348(20):1953-66
pubmed: 12690092
Front Chem. 2014 Aug 25;2:69
pubmed: 25202689
Nanoscale Res Lett. 2018 Feb 07;13(1):44
pubmed: 29417375
Expert Opin Drug Deliv. 2011 Feb;8(2):141-51
pubmed: 21219249
J Nanobiotechnology. 2018 Sep 19;16(1):71
pubmed: 30231877
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Cerebrovasc Dis. 2021;50(2):132-140
pubmed: 33530081
J Phys Chem C Nanomater Interfaces. 2009 May 8;112(22):8251-8258
pubmed: 19727334
Int J Nanomedicine. 2014;9:1-15
pubmed: 24363556
Nano Today. 2021 Feb;36:101019
pubmed: 33178330
Ann Oncol. 2021 Jun;32(6):787-800
pubmed: 33746047
Curr Opin Virol. 2012 Jun;2(3):264-75
pubmed: 22572391
Sens Int. 2021;2:100079
pubmed: 34766049
Nat Commun. 2015 Jul 28;6:7712
pubmed: 26218507
Am J Robot Surg. 2014 Jun;1(1):4-11
pubmed: 26361635
Int J Environ Res Public Health. 2016 Apr 19;13(4):430
pubmed: 27104546
Lancet. 2013 Jun 29;381(9885):2265-72
pubmed: 23727167
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
J Control Release. 2014 Aug 10;187:133-44
pubmed: 24874289
J Virol. 2005 Dec;79(23):14614-21
pubmed: 16282461
APL Mater. 2021 Mar 01;9(3):031112
pubmed: 33842101
Nanomedicine (Lond). 2016 Feb;11(3):189-92
pubmed: 26783731
Phys Chem Chem Phys. 2015 Nov 14;17(42):27981-95
pubmed: 26024211
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
Adv Mater Interfaces. 2019 Nov 8;6(21):1900622
pubmed: 32313805
Nat Biotechnol. 2007 Oct;25(10):1159-64
pubmed: 17873867
Mikrochim Acta. 2020 Nov 5;187(12):639
pubmed: 33151419
N Engl J Med. 2018 Apr 19;378(16):1469-1472
pubmed: 29513615
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Nanobiotechnology. 2020 Sep 5;18(1):125
pubmed: 32891146
Nat Nanotechnol. 2020 Aug;15(8):630-645
pubmed: 32661375
Nanomaterials (Basel). 2021 Feb 07;11(2):
pubmed: 33562310
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2053-2055
pubmed: 33113472
Front Chem. 2014 Aug 27;2:63
pubmed: 25221775
BMJ. 2020 Oct 23;371:m3862
pubmed: 33097561
Emergent Mater. 2021;4(1):363-386
pubmed: 33585793
J Pharm Sci. 2011 Jan;100(1):75-93
pubmed: 20589949
Vaccine. 2014 Oct 21;32(46):6170-6176
pubmed: 25240756
Colloids Surf B Biointerfaces. 2006 Mar 15;48(2):112-8
pubmed: 16520025
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Evid Based Complement Alternat Med. 2015;2015:246012
pubmed: 25861355
Arthritis Rheumatol. 2017 Jun;69(6):1135-1143
pubmed: 28217930
J Appl Physiol (1985). 2006 Oct;101(4):1162-9
pubmed: 16763103
Cell Stem Cell. 2021 Feb 4;28(2):331-342.e5
pubmed: 33450186
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238
pubmed: 32186952
Intervirology. 2020 Dec 9;:1-12
pubmed: 33296901
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
Sensors (Basel). 2020 Nov 18;20(22):
pubmed: 33218097
Nat Nanotechnol. 2020 Aug;15(8):618-621
pubmed: 32728083
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
J Hosp Infect. 2016 Mar;92(3):235-50
pubmed: 26597631
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1):
pubmed: 27312983
ACS Nano. 2020 Apr 28;14(4):3719-3720
pubmed: 32227916
Front Immunol. 2020 Dec 01;11:576818
pubmed: 33335527
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Nat Rev Cardiol. 2020 Sep;17(9):543-558
pubmed: 32690910
P T. 2017 Dec;42(12):742-755
pubmed: 29234213